Glipizide NDC 60760-793

Product information

Brand name (proprietary)

Glipizide

Generic name (nonproprietary)

glipizide

Active ingredients

Glipizide — 10 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

St. Mary's Medical Park Pharmacy

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 206928

Marketing start

Dec 7, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Sulfonylurea Compounds (Chemical structure)

Identifiers

Product ID 60760-793_54db9d72-43f9-652e-e063-6394a90a660aSPL ID 54db9d72-43f9-652e-e063-6394a90a660aSPL set ID 0ccc17ca-fff8-0449-e063-6294a90af36dRxCUI 315107UNII X7WDT95N5C

Pharmacologic class

Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460760079390 followed by a unit qualifier and the quantity Copy

Package 60760-0793-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 206928

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.